Physician profile
Gerald J Shepps
NPI 1538277603
$2,507.13
in general payments reported to CMS, 2019-2025
14 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $283 · 2021: $129 · 2022: $209 · 2023: $295 · 2024: $314 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,025.80 | 2019-2024 | Tecnis Simplicity, Catalys System, Tecnis Iol |
| Alcon Vision LLC | $683.54 | 2022-2025 | Clareon, Rocklatan, Acrysof Iq Panoptix Uv Iol |
| Tarsus Pharmaceuticals, INC. | $205.33 | 2024-2025 | Xdemvy |
| Allergan, INC. | $122.79 | 2019-2021 | |
| Abbvie INC. | $102.05 | 2023-2025 | Lumigan, Alphagan P, Vuity |
| Bausch & Lomb Americas INC. | $71.45 | 2022-2024 | Miebo, Xiidra, Vyzulta |
| Harrow Eye, LLC | $70.26 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $57.00 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.15 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $34.98 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $21.87 | 2022 | |
| Kala Pharmaceuticals, INC. | $21.20 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $21.01 | 2022 | |
| Shire North American Group INC | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Shepps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.